The global Cartilage Repair/Regeneration Market size is expected to value at USD 6.7 billion by 2025. The market is subject to witness a substantial growth due to the increasing occurrence of bone and joint related diseases such as Osteoarthritis (OA) and arthritis, and recent technological advancements in cartilage regeneration. Growing geriatric population in across the globe, is susceptible towards Osteoarthritis (OA) and arthritis due to weakened bone structure. This in return is expected to fuel the growth of cartilage repair/regeneration industry over the forecast period.
Additionally, change in food patterns leading to obesity is considered as one of the prominent factor associated with market growth, in the recent years. Globally, the cartilage repair/regeneration market is predicted to grow at CAGR of 5.4% in forecast period, providing numerous opportunities for market players to invest in research and development in the market.
Growing prevalence of diabetes is considered as one of the critical factors driving the growth of cartilage regeneration industry, in recent years. Diabetes causes loss of cartilage leading to weakened bone structure which requires replacement of the cartilage or regeneration. Additionally, growing prevalence of obesity in various region across the globe is predicted to drive the growth of the market in upcoming years.
The American Heart Association (AHA) has reported that the global geriatric population is expected to account for approximately twenty percent of global population in next two decades. The geriatric population is extremely susceptible to chronic diseases and is predicted to be a critical factor in driving the demand for cartilage repair procedures, thus escalating market growth in the last few years.
Increase in number of road accidents and sports-related injuries across the globe, leading to bone and joint injuries is expected to amplify the demand for cartilage repair procedures in upcoming years. The recent technological advancements in cartilage repair and regeneration procedures coupled with inception of new techniques in the market is prompting adoption of cartilage repair and regeneration procedures in the recent years. Sports injuries are one of the prominent driver for increasing adoption of cartilage repair procedures. Sports such as bicycling, skating, and skateboarding are major sources of sports related injuries.
The cartilage repair market is divided into two major types based on treatment modalities such as cell-based treatment and non-cell-based treatment. Cell-based treatment is considered as one of the fastest growing segment in the market with substantial revenue generation in the last couple of years. Growing popularity of the cell-based treatments are expected to provide lucrative growth opportunities for industry players.
Development of autologous chondrocyte transplants in surgical treatment of damaged articular cartilage including chondral and osteo-chondral lesions has led to growing demand for cartilage repair and regeneration procedures. The non-cell-based segment has also witnessed substantial growth due to lower cost and superior outcomes. The non-cell-based segment is further divided into tissue scaffolds and cell-free composites.
The cartilage repair is classified into palliative and intrinsic repair stimulus. Introduction of advanced treatment methodologies such as visco-supplementation and debridement & lavage procedure are expected to drive demand of palliative repair treatments. Visco-supplement requires injecting of hyaluronic acid onto a joint to isolate and separate synovial fluid during surgical procedure for Osteoarthritis (OA) disorders.
The cartilage regeneration industry is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to rising occurrence of musculoskeletal diseases, growing patient’s pool, and changing lifestyle among individuals. Asia-Pacific region is predicted to hold major market share in the cartilage regeneration market with massive growth in forecast period.
Countries such as India, Australia, China and New Zealand are leading the Asia-Pacific market with growing geriatric population, increasing healthcare expenditure, and significant investment by leading industry players considering potential opportunities in the region. The key players in the cartilage repair/regeneration industry are Zimmer Biomet Holdings, Inc., Stryker Co., DePuySynthes, Inc., Smith & Nephew plc, Vericel Co., Osiris Therapeutics Incorporations, B. Braun Melsungen AG, Anika Therapeutics Incorporations, Arthrex, Incorporations, and Collagen Solutions Plc.
Treatment Modality Outlook (Revenue, USD Million, 2014 - 2025)
• Chondrocyte Transplantation
• Growth Factor Technology
• Tissue Scaffolds
• Cell-Free Composites
Application Outlook (Revenue, USD Million, 2014 - 2025)
• Hyaline Cartilage
Treatment Type Outlook (Revenue, USD Million, 2014 - 2025)
• Debridement & Lavage
• Intrinsic Repair Stimulus
Site Outlook (Revenue, USD Million, 2014 - 2025)
• Knee Cartilage Repair
• Arthroscopic Chondroplasty
• Autologous Chondrocyte
• Osteochondral Grafts Transplantation
• Cell-based Cartilage Resurfacing
Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)
• South Africa
Research Support Specialist, USA
FREE sample contains market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...